Current estimates of fungal disease incidence and mortality are imprecise. Population at risk
denominators were used to estimate annual incidence for 2019–21. Extensive literature …

Siderophores and particular TAFC have the potential to revolutionize diagnostic pathways
for invasive aspergillosis and other mould infections. However, larger multicentre studies are …

Candida parapsilosis is becoming a predominant non-albicans cause of invasive
candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis …

Transplant patients, including solid-organ transplant (SOT) and hematopoietic stem cell
transplant (HSCT) recipients, are exposed to various types of complications, particularly …

Background Risk factors for invasive fungal infections (IFIs) after chimeric antigen receptor-
modified T cells (CAR-T) treatment have been poorly studied. Here we are investigating the …

Abstract Aim Optimization of Candida albicans growth and biofilm formation is essential for
understanding the recalcitrance of this pathogen to advance functional analysis on hospital …

Invasive fungal diseases (IFDs) still represent a relevant cause of mortality in patients
affected by hematological malignancies, especially acute myeloid leukaemia (AML) and …

In October, 2022, WHO published the first fungal priority pathogen list, which categorised 19
fungal entities into three priority groups (critical, high, and medium), for prioritisation of …

Background Scedosporium is a lesser-known non-Aspergillus genus of mold that can
present in unsuspecting ways. If overlooked, it may disseminate and cause high mortality in …

Background Aspergillus species cause a variety of serious clinical conditions with
increasing trend in antifungal resistance. The present study aimed at evaluating hospital …